"Taking Science Personally," a 2008 feature story leading a special section on "Giving" in the New York Times, captures the challenges of speeding drug development for a complex disease — as well as how MJFF is working to tackle them.

Read the full article at the New York Times Web site

Update: August 13, 2010
The New York Times reports on the Parkinson's Progression Markers Initiative (PPMI), MJFF's landmark clinical study aiming to identify biological markers that reveal the progression of PD. Biomarkers are critical to developing long-awaited disease-modifying treatments that will transform patients' lives.